Rachel L Lapidus, MD
Psychiatry · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Momentum for Health · 41 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lapidus’s office at (408) 938-6750 to ask if they take your plan before you enroll.
California Medical Board record
Licence A114105 · Current
Licensed to practise in California · since 2010 · expires 2028-01-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$5,436
Medicare paid this office $5,436 for 19 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 12 | $1,432 | $84 |
Who their Medicare patients are
19 Original Medicare patients in 2024. Average age 45 · Also on Medicaid 100% · Health risk score 0.88. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
The office billed $31,294, Medicare allowed $7,340 and paid $5,436; for 48 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 19 | 48 | 45 | 0.88 | $31,294 | $5,436 |
| 2023 | 13 | 31 | 45 | 0.84 | $11,364 | $3,577 |
| 2022 | 11 | 17 | 43 | 1.26 | $9,260 | $2,427 |
| 2021 | 17 | 411 | 38 | 0.94 | $17,180 | $5,509 |
| 2020 | 27 | 59 | 42 | 0.95 | $26,270 | $6,203 |
| 2019 | 32 | 87 | 45 | 0.99 | $34,875 | $9,078 |
| 2018 | 36 | 91 | 44 | 0.91 | $32,107 | $10,157 |
| 2017 | 19 | 34 | 39 | 1.16 | $12,398 | $3,921 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2021: 1 service
| Psychiatric diagnostic evaluation with medical services | 17 | $3,682 | $11 |
2020: 1 service
| Long return visit (40+ min) | 15 | $2,625 | $105 |
2019: 3 services
| Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | 11 | $2,208 | $116 |
| Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | 13 | $1,912 | $83 |
| Psychiatric diagnostic evaluation with medical services | 14 | $1,459 | $104 |
2018: 3 services
| Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | 13 | $3,512 | $117 |
| New patient custodial care facility, group care, or assisted living visit, typically 75 minutes | 12 | $2,301 | $192 |
| Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | 13 | $1,522 | $80 |
Drugs they prescribed that Part D paid
$56,514
Pharmacies billed $56,514 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 335) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
315 generic and 20 brand-name prescriptions · $56,514 in drug cost · 17 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Invega Sustenna | 15 | $42,169 | $2,811 |
| Divalproex Sodium Er | 13 | $790 | $61 |
| Olanzapine | 24 | $390 | $16 |
| Risperidone | 12 | $342 | $29 |
| Bupropion Xl | 31 | $221 | $7 |
See all 13 drugs
| Invega Sustenna | 15 | $42,169 | $2,811 |
| Divalproex Sodium Er | 13 | $790 | $61 |
| Olanzapine | 24 | $390 | $16 |
| Risperidone | 12 | $342 | $29 |
| Bupropion Xl | 31 | $221 | $7 |
| Duloxetine | 18 | $192 | $11 |
| Hydroxyzine | 14 | $186 | $13 |
| Buspirone | 20 | $182 | $9 |
| Quetiapine | 11 | $132 | $12 |
| Escitalopram | 18 | $94 | $5 |
| Trazodone | 14 | $91 | $7 |
| Clonazepam | 13 | $72 | $6 |
| Sertraline | 11 | $42 | $4 |
Year by year
| 2024 | 335 | 43 | 0% (0) | 6% | $56,514 |
| 2023 | 194 | 39 | 0% (0) | None | $39,051 |
| 2022 | 261 | 42 | 0% (0) | 15% | $104,903 |
| 2021 | 316 | 41 | 0% (0) | 14% | $95,588 |
| 2020 | 434 | 75 | 0% (0) | 12% | $101,746 |
| 2019 | 459 | 65 | 0% (0) | 14% | $91,831 |
| 2018 | 322 | 77 | 0% (0) | 13% | $67,102 |
| 2017 | 397 | 79 | 0% (0) | None | $62,663 |
| 2016 | 374 | 80 | 0% (0) | 13% | $31,192 |
| 2015 | 221 | 50 | 0% (0) | 12% | $17,208 |
| 2014 | 203 | 69 | 0% (0) | 14% | $26,938 |
| 2013 | 244 | 44 | 0% (0) | 22% | $39,283 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Olanzapine Odt | 13 | $561 | $43 |
| Olanzapine | 17 | $537 | $32 |
| Benztropine Mesylate | 15 | $193 | $13 |
2022: 8 drugs
| Invega Sustenna | 26 | $74,130 | $2,851 |
| Quetiapine | 18 | $575 | $32 |
| Olanzapine | 24 | $571 | $24 |
| Risperidone | 14 | $176 | $13 |
| Trazodone | 21 | $168 | $8 |
| Sertraline | 12 | $121 | $10 |
| Metformin | 12 | $62 | $5 |
| Atorvastatin | 11 | $62 | $6 |
2021: 11 drugs
| Invega Sustenna | 31 | $73,207 | $2,362 |
| Aripiprazole | 22 | $2,787 | $127 |
| Naltrexone | 16 | $487 | $30 |
| Divalproex | 21 | $397 | $19 |
| Olanzapine | 17 | $367 | $22 |
| Bupropion Xl | 14 | $359 | $26 |
| Risperidone | 21 | $183 | $9 |
| Benztropine Mesylate | 12 | $176 | $15 |
| Gabapentin | 11 | $121 | $11 |
| Trazodone | 18 | $114 | $6 |
| Sertraline | 16 | $95 | $6 |
2020: 15 drugs
| Invega Sustenna | 33 | $70,608 | $2,140 |
| Aripiprazole | 28 | $1,583 | $57 |
| Olanzapine | 56 | $894 | $16 |
| Olanzapine Odt | 11 | $885 | $80 |
| Divalproex Sodium Er | 11 | $406 | $37 |
| Divalproex | 18 | $277 | $15 |
| Benztropine Mesylate | 17 | $212 | $12 |
| Hydroxyzine | 12 | $194 | $16 |
| Valproic Acid | 11 | $173 | $16 |
| Propranolol | 12 | $161 | $13 |
| Lithium Carbonate Er | 15 | $160 | $11 |
| Risperidone | 24 | $135 | $6 |
| Fluoxetine | 11 | $64 | $6 |
| Metformin Hcl Er | 14 | $44 | $3 |
| Sertraline | 14 | $42 | $3 |
2019: 14 drugs
| Invega Sustenna | 30 | $57,070 | $1,902 |
| Olanzapine Odt | 27 | $1,186 | $44 |
| Haloperidol Decanoate | 11 | $690 | $63 |
| Aripiprazole | 17 | $537 | $32 |
| Olanzapine | 53 | $531 | $10 |
| Risperidone | 28 | $428 | $15 |
| Benztropine Mesylate | 45 | $347 | $8 |
| Propranolol | 21 | $333 | $16 |
| Haloperidol | 11 | $236 | $21 |
| Divalproex | 18 | $176 | $10 |
| Lithium Carbonate | 11 | $92 | $8 |
| Atorvastatin | 15 | $90 | $6 |
| Sertraline | 11 | $88 | $8 |
| Fluoxetine | 12 | $65 | $5 |
2018: 9 drugs
| Invega Sustenna | 24 | $46,634 | $1,943 |
| Clozapine Odt | 12 | $2,447 | $204 |
| Olanzapine | 34 | $966 | $28 |
| Divalproex | 19 | $336 | $18 |
| Benztropine Mesylate | 26 | $273 | $11 |
| Quetiapine | 17 | $257 | $15 |
| Risperidone | 22 | $254 | $12 |
| Trazodone | 11 | $129 | $12 |
| Gabapentin | 11 | $89 | $8 |
2017: 16 drugs
| Invega Sustenna | 17 | $30,987 | $1,823 |
| Aripiprazole | 16 | $1,698 | $106 |
| Fluphenazine | 12 | $1,153 | $96 |
| Sertraline | 29 | $1,130 | $39 |
| Venlafaxine Hcl Er | 14 | $1,040 | $74 |
| Bupropion Xl | 11 | $852 | $77 |
| Bupropion Hcl Sr | 21 | $626 | $30 |
| Gabapentin | 16 | $483 | $30 |
| Mirtazapine | 20 | $478 | $24 |
| Escitalopram | 13 | $351 | $27 |
| Divalproex | 12 | $347 | $29 |
| Trazodone | 16 | $291 | $18 |
| Olanzapine | 16 | $261 | $16 |
| Fluoxetine | 17 | $234 | $14 |
| Quetiapine | 13 | $196 | $15 |
| Lorazepam | 11 | $135 | $12 |
2016: 15 drugs
| Aripiprazole | 16 | $5,621 | $351 |
| Sertraline | 29 | $1,164 | $40 |
| Venlafaxine Hcl Er | 17 | $880 | $52 |
| Duloxetine | 14 | $756 | $54 |
| Bupropion Hcl Sr | 17 | $620 | $36 |
| Eszopiclone | 11 | $606 | $55 |
| Olanzapine | 19 | $574 | $30 |
| Gabapentin | 11 | $572 | $52 |
| Mirtazapine | 18 | $506 | $28 |
| Escitalopram | 17 | $439 | $26 |
| Fluoxetine | 34 | $425 | $13 |
| Trazodone | 15 | $270 | $18 |
| Lorazepam | 19 | $251 | $13 |
| Alprazolam | 25 | $191 | $8 |
| Clonazepam | 11 | $104 | $9 |
2015: 6 drugs
| Venlafaxine Hcl Er | 18 | $749 | $42 |
| Sertraline | 15 | $551 | $37 |
| Mirtazapine | 14 | $472 | $34 |
| Trazodone | 18 | $302 | $17 |
| Fluoxetine | 25 | $298 | $12 |
| Lorazepam | 14 | $182 | $13 |
2014: 6 drugs
| Sertraline | 16 | $693 | $43 |
| Mirtazapine | 14 | $593 | $42 |
| Buspirone | 13 | $327 | $25 |
| Trazodone | 15 | $250 | $17 |
| Lorazepam | 16 | $212 | $13 |
| Fluoxetine | 13 | $142 | $11 |
2013: 9 drugs
| Abilify | 22 | $16,532 | $751 |
| Quetiapine | 16 | $998 | $62 |
| Olanzapine | 12 | $469 | $39 |
| Clonazepam | 34 | $250 | $7 |
| Lamotrigine | 17 | $173 | $10 |
| Trazodone | 17 | $170 | $10 |
| Lorazepam | 14 | $114 | $8 |
| Fluoxetine | 13 | $93 | $7 |
| Topiramate | 12 | $64 | $5 |
Money from drug and device companies
$235 in 2025
| 2025 | 2 | 2 | None | $235 |
| 2023 | 1 | 1 | None | $117 |
| 2019 | 3 | 3 | None | $375 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Cobenfy | $119 | 1 payment
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $116 | 1 payment
|
See all 2 published payments
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-13 | Caplyta | $116 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-20 | Cobenfy | $119 |
See earlier years (2023, 2019)
2023: $117
| Alkermes | Lybalvi | $117 | 1 payment
|
2019: $375
| Neurocrine Biosciences | Ingrezza | $125 | 1 payment
|
| Janssen Pharmaceuticals | None | $125 | 1 payment
|
| Alkermes | Aristada | $125 | 1 payment
|
Professional record
- NPI
- 1093944019
- Licence
- CA A114105California A114105: Current · expires 2028-01-31
- Trained
- Harvard Medical School, 2009
- Group
- Momentum for Health
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 2001 the Alameda, San Jose, CA, 95126
- NPI first listed
- 2009-07-12
- NPI last updated
- 2022-07-21
This is when the NPI record was last certified, not a medical board exam.